- Version 1
- Download 31
- File Size 508.58 KB
- File Count 1
- Create Date March 18, 2022
- Last Updated March 18, 2022
Johannes Duell 10.3324.haematol.2020.275958
Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma
Attached Files
| File | Action |
|---|---|
| 10314-Article Text-75832-2-10-20210830.pdf | Download |